ANTIPLATELET THERAPY
Clinical trials for ANTIPLATELET THERAPY explained in plain language.
Never miss a new study
Get alerted when new ANTIPLATELET THERAPY trials appear
Sign up with your email to follow new studies for ANTIPLATELET THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could LVAD patients ditch aspirin? new trial aims to find out
Disease control Not yet recruitingThis study tests whether patients with a heart pump (LVAD) can safely stop taking aspirin while continuing warfarin. The goal is to reduce bleeding problems without increasing dangerous clots. About 370 participants will be randomly assigned to receive either aspirin or a placebo…
Matched conditions: ANTIPLATELET THERAPY
Phase: PHASE4 • Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Heart patients may ditch blood thinners after one year, major trial investigates
Disease control Not yet recruitingThis study looks at whether people who had a heart procedure with a drug-coated balloon can safely stop taking antiplatelet drugs after 12 months. The goal is to see if stopping reduces bleeding risks while keeping the heart protected. About 1,000 adults who have been event-free …
Matched conditions: ANTIPLATELET THERAPY
Phase: NA • Sponsor: Ulsan University Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Could 7 days of dual blood thinners be enough for elderly heart patients?
Disease control Not yet recruitingThis study looks at whether older adults (65+) who get a heart stent can safely stop one of their blood thinners (aspirin) after just 7 days instead of the usual 3 to 12 months. The goal is to see if this shorter treatment reduces bleeding risks without increasing heart attacks, …
Matched conditions: ANTIPLATELET THERAPY
Phase: PHASE3 • Sponsor: Vincent ROULE • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC